MY140251A - Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals - Google Patents

Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals

Info

Publication number
MY140251A
MY140251A MYPI20080798A MY140251A MY 140251 A MY140251 A MY 140251A MY PI20080798 A MYPI20080798 A MY PI20080798A MY 140251 A MY140251 A MY 140251A
Authority
MY
Malaysia
Prior art keywords
disorders
thiadiazol
amides
processes
sulfonic acid
Prior art date
Application number
Inventor
Schoenafinger Karl
Keil Stefanie
Urmann Matthias
Matter Hans
Glien Maike
Wendler Wolfgang
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MY140251A publication Critical patent/MY140251A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE INVENTION RELATES TO BICYCLIC ARYL-SULFONIC ACID [1,3,4] THIADIAZOL-2-YL-AMIDES OF THE FORMULA (1) AND TO THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS AND PHYSIOLOGICALLY FUNCTIONAL DERIVATIVES SHOWING PPARDELTA, -ALPHA AND -GAMMA AGONIST ACTIVITY, IN WHICH THE RADICALS ARE AS DEFINED, AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS AND PROCESSES FOR THEIR PREPARATIONS. THE COMPOUNDS ARE SUITABLE FOR THE TREATMENT AND/OR PREVENTION OF DISORDERS OF FATTY ACID METABOLISM AND GLUCOSE UTILIZATION DISORDERS AS WELL AS OF DISORDERS IN WHICH INSULIN RESISTANCE IS INVOLVED AND DEMYELINATING AND OTHER NEURODEGENERATIVE DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM.
MYPI20080798 2005-10-06 2008-03-24 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals MY140251A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05021785 2005-10-06

Publications (1)

Publication Number Publication Date
MY140251A true MY140251A (en) 2009-12-31

Family

ID=35459548

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20080798 MY140251A (en) 2005-10-06 2008-03-24 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals

Country Status (2)

Country Link
MY (1) MY140251A (en)
TW (1) TW200730516A (en)

Also Published As

Publication number Publication date
TW200730516A (en) 2007-08-16

Similar Documents

Publication Publication Date Title
TN2009000242A1 (en) Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
MY148982A (en) Phenyl-1,2,4-oxadiazolone derivative with phenyl group, processes for their preparation and their use as pharmaceuticals
TNSN08148A1 (en) Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
MX2010006647A (en) Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals.
TW200505880A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
MY142431A (en) Oxadiazolones, processes for their preparation and their use as pharmaceuticals
MA32323B1 (en) Heterocyclic n-ring sulfonamides with oxadiazolone group, methods of preparation and use as pharmaceutical agents
MXPA05013712A (en) Propionic acid derivatives useful in the treatment of lipid disorders.
TW200508210A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
MX2007002689A (en) 7-azaindoles and their use as ppar agonists.
NO20081682L (en) 4-Oxy-N- [1,3,4] -thiadiazol-2-yl-benzenesulfonamides, process for their preparation and their use as pharmaceuticals
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson's disease
WO2008010238A3 (en) Antidiabetic azabicyclo [3. 1. 0] hexan compounds
NO20081681L (en) N- [1,3,4] -thiadiazol-2-yl-benzenesulfonamides, process for their preparation and their use as pharmaceuticals
TW200621732A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
WO2007039174A3 (en) Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
NO20081675L (en) Cyclic N- [1,3,4] -thiadiazol-2-yl-benzenesulfonamides, process for their preparation and their use as pharmaceuticals
TW200510399A (en) 1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
TW200505830A (en) Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
TW200732328A (en) Derivatives of 2-aminothiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
MY140251A (en) Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
TW200505831A (en) Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals
WO2007026254A3 (en) Benzodiazepine derivatives , their preparation and the therapeutic use thereof
TW200508229A (en) Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals